Cre-dependent DNA recombination activates a STING-dependent innate immune response.
Geneviève PépinJonathan FerrandKlara HöningW Samantha N JayasekaraJason E CainMark A BehlkeDaniel J GoughBryan R G WilliamsVeit HornungMichael P GantierPublished in: Nucleic acids research (2016)
Gene-recombinase technologies, such as Cre/loxP-mediated DNA recombination, are important tools in the study of gene function, but have potential side effects due to damaging activity on DNA. Here we show that DNA recombination by Cre instigates a robust antiviral response in mammalian cells, independent of legitimate loxP recombination. This is due to the recruitment of the cytosolic DNA sensor STING, concurrent with Cre-dependent DNA damage and the accumulation of cytoplasmic DNA. Importantly, we establish a direct interplay between this antiviral response and cell-cell interactions, indicating that low cell densities in vitro could be useful to help mitigate these effects of Cre. Taking into account the wide range of interferon stimulated genes that may be induced by the STING pathway, these results have broad implications in fields such as immunology, cancer biology, metabolism and stem cell research. Further, this study sets a precedent in the field of gene-engineering, possibly applicable to other enzymatic-based genome editing technologies.
Keyphrases
- circulating tumor
- dna damage
- cell free
- single molecule
- immune response
- dna repair
- stem cells
- genome editing
- genome wide
- single cell
- crispr cas
- cell therapy
- oxidative stress
- circulating tumor cells
- nucleic acid
- genome wide identification
- radiation therapy
- dendritic cells
- dna methylation
- gene expression
- risk assessment
- nitric oxide
- mesenchymal stem cells
- genome wide analysis
- bone marrow
- transcription factor
- human health